dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorCETEM
dc.contributorUniversidade Federal de São Carlos (UFSCar)
dc.date.accessioned2018-12-11T17:18:18Z
dc.date.available2018-12-11T17:18:18Z
dc.date.created2018-12-11T17:18:18Z
dc.date.issued2017-01-01
dc.identifierMetal Nanoparticles in Pharma, p. 77-99.
dc.identifierhttp://hdl.handle.net/11449/175957
dc.identifier10.1007/978-3-319-63790-7_5
dc.identifier2-s2.0-85042638965
dc.description.abstractIn the past few years, due to the rapid development of the advances in the pharmaceutical and biomedical field, the magnetic iron-oxide nanoparticles have received considerable attention for their attractive properties. Magnetic nanoparticles are perfect candidates for use in diagnosis and disease treatment because they have properties as superparamagnetic behavior, a high superficial area that allows functionalizing, biocompatibility, nanometric size (10-100 nm), low toxicity, possibility of in vivo manipulation by a low external magnetic field, and placement in a specific place. The key point of magnetic iron-oxide nanomaterials is to develop effective synthesis techniques that allow particles to have with a uniform size, high magnetic saturation, and stability, preventing aggregation and oxidation with air since these result in the loss of its magnetic properties. This chapter presents a review of various strategies to synthesis of magnetic nanoparticles and their use in pharmaceutical and biomedical field.
dc.languageeng
dc.relationMetal Nanoparticles in Pharma
dc.rightsAcesso restrito
dc.sourceScopus
dc.subjectBiomedical application
dc.subjectMagnetic iron-oxide nanoparticles
dc.subjectPharmacological activity
dc.subjectSynthesis techniques
dc.titlePharmaceutical and biomedical applications of magnetic iron-oxide nanoparticles
dc.typeCapítulos de libros


Este ítem pertenece a la siguiente institución